RSS-Feed abonnieren
PDF herunterladen
DOI: 10.1055/s-0040-1715183
Three Case Reports of Intravenous Leiomyomatosis with Intracardiac Extensions
Funding This research was not supported by any specific grants from funding agencies in the public, commercial, or not-for-profit sectors.
Abstract
Background Intravenous leiomyomatosis is a rare disease. Histologically, intravenous leiomyomatosis is a benign tumor, but its biological behavior can be malignant. The development of intracardiac extensions leads to congestive heart failure and occasionally sudden fatalities.
Case Description The cases of three patients treated at our university between 2017 and 2018 were studied retrospectively. Intravenous tumors extending into the right heart system were fully removed without perioperative complications or death. Only one tumor recurrence was observed during the followed-up period.
Conclusion The gold standard for the treatment of intravenous leiomyomatosis with intracardiac extension is complete and successful surgical resection.
Authors' contributions
Yundan Deng contributed to project development, data collection, data analysis, and manuscript writing. Bing Song contributed to project development and data analysis.
Publikationsverlauf
Eingereicht: 25. April 2020
Angenommen: 02. Juni 2020
Artikel online veröffentlicht:
18. September 2020
© 2020. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Georg Thieme Verlag KG
Stuttgart · New York
-
References
- 1 Li B, Chen X, Chu YD, Li RY, Li WD, Ni YM. Intracardiac leiomyomatosis: a comprehensive analysis of 194 cases. Interact Cardiovasc Thorac Surg 2013; 17 (01) 132-138
- 2 Lee S, Kim DK, Narm KS, Cho SH. Pulmonary artery embolization of intravenous leiomyomatosis extending into the right atrium. Korean J Thorac Cardiovasc Surg 2011; 44 (03) 243-246
- 3 Worley Jr MJ, Aelion A, Caputo TA. , et al. Intravenous leiomyomatosis with intracardiac extension: a single-institution experience. Am J Obstet Gynecol 2009; 201 (06) 574.e1-574.e5
- 4 Lo KW, Lau TK. Intracardiac leiomyomatosis. Case report and literature review. Arch Gynecol Obstet 2001; 264 (04) 209-210
- 5 Dal Cin P, Quade BJ, Neskey DM, Kleinman MS, Weremowicz S, Morton CC. Intravenous leiomyomatosis is characterized by a der(14)t(12;14)(q15;q24). Genes Chromosomes Cancer 2003; 36 (02) 205-206
- 6 Lam PM, Lo KW, Yu MY. , et al. Intravenous leiomyomatosis: two cases with different routes of tumor extension. J Vasc Surg 2004; 39 (02) 465-469
- 7 Tang L, Lu B. Intravenous leiomyomatosis of the uterus: a clinicopathologic analysis of 13 cases with an emphasis on histogenesis. Pathol Res Pract 2018; 214 (06) 871-875
- 8 Wang J, Yang J, Huang H. , et al. Management of intravenous leiomyomatosis with intracaval and intracardiac extension. Obstet Gynecol 2012; 120 (06) 1400-1406
- 9 Zhang C, Miao Q, Liu X. , et al. Intravenous leiomyomatosis with intracardiac extension. Ann Thorac Surg 2010; 89 (05) 1641-1643
- 10 Yu HY, Tsai HE, Chi NH. , et al. Long-term outcomes of surgical treatment for intravascular leiomyomatosis. J Formos Med Assoc 2018; 117 (11) 964-972
- 11 Wu CK, Luo JL, Yang CY. , et al. Intravenous leiomyomatosis with intracardiac extension. Intern Med 2009; 48 (12) 997-1001